Physician profile
Paul Brady
NPI 1760468128
$20,005,211.84
in general payments reported to CMS, 2019-2025
22 companies · $6.1M in 2025
The $6.1M reported for 2025 was more than what 99% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $967K · 2020: $1.0M · 2021: $1.5M · 2022: $2.1M · 2023: $3.7M · 2024: $4.6M · 2025: $6.1M.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $14M · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $160K · Consulting Fee: $94K · Travel and Lodging: $30K · Food and Beverage: $5,502.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $14,175,589.57 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $160,297.34 |
| Consulting Fee | $94,170.48 |
| Travel and Lodging | $29,931.82 |
| Food and Beverage | $5,501.63 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $20,001,446.17 | 2019-2025 | Arthrex, Capital Consumables Consumables Blades & Burrs S Blades & Burrs |
| Alpha Orthopedic Systems | $1,984.80 | 2019-2023 | |
| Smith+Nephew, INC. | $395.37 | 2019-2025 | Aetos Shoulder System, Tandem, Real Intelligence |
| Smoky Mountain Surgical LLC | $332.93 | 2023-2025 | |
| Ferring Pharmaceuticals INC. | $259.56 | 2019-2025 | Euflexxa |
| Radius Health, INC. | $154.54 | 2020-2025 | Tymlos |
| Stryker Corporation | $143.95 | 2024 | 1788 |
| Gemini Medical LLC | $122.66 | 2021 | |
| Vertex Pharmaceuticals Incorporated | $62.69 | 2024-2025 | |
| Amgen INC. | $52.93 | 2019 | |
| Horizon Therapeutics Plc | $50.02 | 2019-2022 | |
| Pacira Pharmaceuticals Incorporated | $38.46 | 2023-2024 | Iovera, Zilretta, Exparel |
| Mid-Atlantic Surgical Systems, LLC | $32.85 | 2024 | |
| Djo, LLC | $21.05 | 2024 | Cmf |
| C. R. Bard, INC. & Subsidiaries | $19.27 | 2023 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Davol INC. | $17.36 | 2024 | |
| Ethicon US, LLC | $17.07 | 2022 | |
| Innovation Technologies INC | $16.66 | 2024 | Irrisept |
| Sanara Medtech INC. | $13.70 | 2023 | Celleraterx |
| Depuy Synthes Sales INC. | $12.98 | 2022 | |
| Kowa Pharmaceuticals America, INC. | $11.87 | 2022 | |
| Kinex Medical Company LLC | $4.95 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Paul Brady listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.